Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

13 Jun 2007 15:37

Creon Corporation PLC13 June 2007 Creon Corporation PLC (the "Company") Notifiable Interest Creon Corporation PLC announces that it received notice on 7 June 2007 fromEquity Special Situations Limited advising that following an acquisition ofordinary shares of 1p each in the Company, on 6 June 2007, Equity SpecialSituations Limited now hold a direct interest in 3,010,000 ordinary shares inthe capital of the Company. This represents approximately 29.99% of the issuedordinary share capital of the Company. For further information, please contact: Jonathan Freeman, DirectorCreon Corporation PLC Tel: 01600 750 432 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.